Washington University in St. Louis, School of Medicine
St Louis, Missouri, 63110, United States
Location status: Recruiting
Location contact
Erin Kasson
CONTACT
Patricia Cavazos-Rehg, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05994209
Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effects of vaping products, health information about vaping has been somewhat unclear in regards to associated health risks. Teens and young adults may be reluctant to disclose their use of vaping products to parents or health providers and instead turn to social media to share and seek out information regarding vaping risks and cessation supports. Thus, our current proposal outlines the use of social media to identify teens and young adults socially networking about vaping, the use of an online chatbot screen to evaluate individual cessation support needs, and the use of a digital intervention system to support vaping cessation. The mobile intervention used in this study is based on a widely-used evidence-based mobile intervention for combustible smoking (i.e., quitSTART) and has been adapted for vaping and young adults to include an in-app chatbot to guide users to tailored content and to motivate and encourage their cessation efforts. We aim to integrate our social media recruitment and online screening approach to connect individuals with this mobile app intervention, and will conduct a randomized controlled trial to evaluate user engagement with and preliminary efficacy of the digital intervention on reducing vaping behaviors among teens and young adults.
Interested in participating?
Request Info15 year–25 year
All sexes
Interventional
Phase 1
St Louis, Missouri, 63110, United States
Location status: Recruiting
Erin Kasson
CONTACT
Patricia Cavazos-Rehg, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.
In-App chatbot feature emedded into quitSTART mobile application to motivate vaping cessation and support app navigation.
Time frame: Baseline, 6 weeks, 3 months
Vaping cessation as assessed by 7 day self-reported vaping abstinence at follow-up. Timeline follow back procedures will be used to establish abstinence or if participants lapsed (their first instance of vaping post quit) or relapsed (vaped on 7 consecutive days) at each follow up time point.
Time frame: Baseline, 6 weeks, 3 months
Nicotine dependence will be assessed using the 4-item Patient-Reported Outcomes Measurement Information System (PROMIS).
Time frame: Baseline, 6 weeks, 3 months
Perceived risks of vaping, both general and conditional, will be assessed with two items adapted from Wackowski et al., 2020. "How harmful, if at all, do you think vaping/using an e-cigarette is to a user's health?" (general) and "Imagine you vaped/used e-cigarettes daily for the next 10 years and used no other tobacco product. How harmful do you think this vaping would be to your health?" (conditional), both using a five-point response scale (not at all-extremely harmful).
Time frame: Baseline, 6 weeks, 3 months
Data automatically captured within the chatbot, and app platform will be used to calculate a composite measure of engagement for those randomized to each of these intervention components and will be examined as a predictor of outcomes. We will use a modified version of an app Engagement Index (EI).
Contact information is provided by the study sponsor or research team.
Erin Kasson, MSW
CONTACT
Patricia Cavazos-Rehg, PhD
CONTACT
Washington University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05897242
Behavior, Chemically-Induced Disorders
Seattle, Washington, United States
View Trial DetailsNCT05962229
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT05430334
Behavior, Chemically-Induced Disorders
Beirut, Lebanon
View Trial DetailsNCT06662305
Behavior, Nicotine Vaping
New Haven, Connecticut, United States
View Trial Details